Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare diseases drugmaker soaring. One of SpringWorks’ drugs, Ogsiveo ...

NEW YORK/FRANKFURT (Reuters) – Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics ...

09:50 EST Merck KGaA (MKGAY) in talks to buy SpringWorks Therapeutics (SWTX), Reuters reports Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

Merck KGaA (MKGAY), the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks Therapeutics (SWTX), Reuters’ Sabrina Valle ...

The exact terms of a potential deal weren't known. Germany's Merck confirmed that it's in talks with SpringWorks (NASDAQ:SWTX) on a potential deal, according to a statement on Monday. There is no ...

Germany's Merck KGaA is in advanced talks to buy U.S. cancer and rare diseases biotech company Springworks Therapeutics, Reuters says, citing unnamed sources. -- The deal could be finalized in the ...

Outgoing president and CEO Ernest Cu thinks his successor should focus on fine-tuning the business As Ernest Cu prepares to step down as Globe Telecom’s president and chief executive officer in ...

Russia's opening gambit ahead of expected peace talks has been laid out in the media, says our Moscow correspondent Ivor Bennett. "There has been a lot of talk about potential meetings and contact ...

NEW YORK/FRANKFURT (Reuters) - Merck (NSE:PROR) KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics ...

Russia's opening gambit ahead of expected peace talks has been laid out in the mieda, says our Moscow correspondent Ivor Bennett. "There has been a lot of talk about potential meetings and contact ...